№ lp_1_2_23196
File format: docx Character count: 89676 File size: 304 KB
Ranibizumab is proposed for listing in the PBS for the treatment of proliferative diabetic retinopathy without diabetic macular oedema based on a cost-utility analysis comparing it to panretinal laser photocoagulation.
Year: 2020
Region / City: Australia
Topic: Medical Treatment, Pharmaceutical
Document Type: Submission
Organ / Institution: Novartis Pharmaceuticals Australia Pty Limited
Author: Not specified
Target Audience: Healthcare professionals, policymakers
Period of Validity: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Time out before intravitreal injections
Year: 2016
Region / City: United States
Topic: Ophthalmology, Risk Management
Document Type: Risk Management Recommendations
Organization / Institution: OMIC
Author: Anne M. Menke, Pauline Merrill, Trexler M. Topping, George Williams
Target Audience: Ophthalmologists, Healthcare Providers
Period of Validity: Not specified
Approval Date: 8/26/16
Date of Changes: Not specified
Effect of unilateral intravitreal bevacizumab on contralateral eye and associated factors in patients with diabetic macular edema at KCMC 2024-2025
Year: 2024-2025
Region / city: Moshi, Tanzania
Subject: Diabetic Macular Edema, Intravitreal Bevacizumab
Document Type: Research Article
Organization / Institution: Kilimanjaro Christian Medical Centre (KCMC)
Author: Not specified
Target Audience: Healthcare professionals, researchers in ophthalmology
Period of Application: June 2024 - July 2025
Approval Date: Not specified
Date of Changes: Not specified
Topics: proliferative RANIBIZUMAB intravitreal